News | May 06, 2010

Surgery Too Soon After Stenting Raises Heart Risks


May 6, 2010 – Patients who can postpone noncardiac surgery for at least six weeks after receiving a coronary stent are less likely to suffer reduced blood flow to the heart, heart attack and death than those who have surgery sooner. This was the finding of Scottish researchers in Circulation: Cardiovascular Interventions, an American Heart Association journal.

Stents are used in more than 90 percent of angioplasty patients in Scotland, according to the study. In the broad retrospective study, researchers found that 42 percent of patients undergoing noncardiac surgery within six weeks of stent implantation were more likely to suffer heart complications, including decreased blood flow to the heart (ischemia), heart attack and death. In comparison, these complications occurred in 13 percent of patients whose surgeries were performed beyond six weeks post-implantation.
The risk of heart problems following noncardiac surgery was even greater among patients whose stents were inserted as treatment for a recent heart attack (occurring in 65 percent of patients) than among those with stable but chronic disease (occurring in 32 percent of patients). The type of stent — bare metal vs. drug-eluting — didn't affect risk, which was similar for the first two years after stent implantation.

The researchers examined records for 1,953 patients, with an average age of 64, who received coronary stents in Scotland between April 2003 and March 2007. They used hospital admission data and information from the Scottish Coronary Revascularization Register.

Previous studies have found that patients who underwent noncardiac surgery within four to six weeks of bare-metal stent implantation had a greater incidence of serious heart complications. However, those studies did not clarify how long the risk persisted after stent implantation and whether it was the same in patients with drug-eluting stents.

"These findings have important implications for a large number of patients," said Nicholas L.M. Cruden, Ph.D., M.B., first author of the study and cardiology lecturer at the University of Edinburgh in Scotland. "In the current study, 4.4 percent of patients undergoing percutaneous coronary intervention underwent noncardiac surgery within one year of coronary stent implantation."

A Health Services Research Grant from the Scottish government's Chief Scientist Office funded this study.

Stent Stats from the American Heart Association

• More than 70 percent of coronary angioplasty procedures in the United States also include stenting.

• In 2006, about 65 percent of percutaneous coronary intervention (PCI) procedures were performed on men, and approximately 50 percent were performed on people age 65 or older.

• In 2006, an estimated 1,313,000 PCI procedures were performed in the United States.

• In 2006, approximately 76 percent of stents implanted during PCI were drug-eluting, compared with 24 percent bare-metal stents.

• In 2006, there were 652,000 PCI procedures with stents – 425,000 in men, 227,000 in women.

For more information: www.americanheart.mediaroom.com


Related Content

News | Cardiovascular Clinical Studies

April 24, 2024 —Hello Heart, a digital leader in preventive heart health, today announced results from its latest study ...

Home April 24, 2024
Home
News | Cardiovascular Clinical Studies

April 22, 2024 — Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, welcomes the ...

Home April 22, 2024
Home
News | Cardiovascular Clinical Studies

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

Home April 16, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Using a web application to qualify individuals for treatment with a nonprescription statin closely ...

Home April 09, 2024
Home
Subscribe Now